Downregulation of the elongation of long-chain fatty acid family members 3 and 6 (ELOVL3 and ELOVL6) in AD lesions is consistent with the expression of long-chain fatty acid-containing LPC [34]. This evidence concerns the gene ELOVL3 and Alzheimer disease.